Data using XPRIZE supplied contrived fluid samples provides results comparable to those seen in the FDA lab testing of donor saliva, as DECN competes for the $5 million prize and GLOBAL validation

LOS ANGELES, CA / ACCESSWIRE / November 23, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics.co, a leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters along with its subsidiary Pharma Tech Solutions, Inc., the inventor/manufacturer of the GenViro! Covid-19 Swift Kit truly rapid testing methodology, today announced the results of the completion of its testing for the world-renown XPRIZE, www.xprize.org. The results from the GenViro! testing, using simulated Covid samples and protocols provided by XPRIZE, provided results in 4-9 seconds that were consistent with what the company reports seeing in the FDA lab human donor testing it is concluding at its certified lab and from human donor tests run in the laboratory of its Korean partner.

XPRIZE is the world's leader in designing and operating incentive competitions to solve humanity's grand challenges, in collaboration with OpenCovidScreen, a non-profit founded by scientists and business leaders to drive needed innovation through "Open Science." OpenCovidScreen, was founded along with a coalition of partners calling for the global community to develop accurate, frequent, fast-turnaround, affordable, and easy-to-use screening tests to detect Covid-19 occurrences before they become outbreaks. The $5 million XPRIZE Rapid Covid Testing competition is designed to accelerate the development of high-quality Covid-19 testing that is low cost, reliable, easy to use, and has a fast fast-turnaround, thereby enabling frequent testing.

"While we were guarded about working in the limited time frame provided for the testing on previously unknown and "contrived" samples, we nevertheless anticipated doing especially well on the testing given our faith and belief in our product. I am more than pleased, pleasantly surprised I would add, with the resulting data," said CEO Keith Berman. "We remain more than emboldened about the overall efficacy of the GenViro! Swift Kits. The results provided an identification dichotomy, perhaps for the first time giving rise to a testing category nomenclature for our noteworthy GenViro! Swift product."

DECN's subsidiary Pharma Tech Solutions, conducted its XPRIZE testing at the laboratory of its Korean partner, using the 88 samples provided by the XPRIZE committee. The week-long testing period included two days needed to thaw out the samples, which were received frozen in dry ice. Samples were triple tested in a blind study under the protocols set by the committee. The results have been submitted to the XPRIZE committee for consideration as a finalist, and their announcement is tentatively planned for release on or around December 8th.

The XPRIZE Rapid Covid Testing competition calls on the world's brightest, most innovative minds to develop new, low-cost testing solutions that range from testing devices with 15-minute results to distributed lab testing methods with "next morning" results. Frequent, fast-turnaround, easy-to-use testing enables effective data-driven tracing and isolating strategies. Many currently available Covid-19 tests remain expensive, slow, invasive, and are supply-chain limited. XPRIZE Rapid Covid Testing aims to meet the need to scale testing capabilities by approximately 100-times above our current standards, the level needed to more safely return to everyday activities, especially in times of increased community spread.

To amplify its impact, a $50 million "COVID Apollo Project" led by experienced life sciences investors and company builders – including RA Capital, Bain Capital, Perceptive Advisors, Redmile Group, and Samsara Biocapital – will work with OpenCovidScreen, the XPRIZE community, and others to accelerate the best ideas, technologies, and innovations to market and scale them.

Teams can compete in one of the following four categories: At Home, Point-of-Care, Distributed Lab, or High-Throughput Lab. To ensure supply chain diverse solutions, entries are encouraged in a variety of underlying testing approaches (PCR, Isothermal/LAMP/RPA, CRISPR, Antigen-detection, Next Generation Sequencing, and other technologies). Entries will be judged on overall innovation of solution, appropriate performance, turnaround time, scaling properties and frequency enabled, ease-of-use and cost of solution.

Seven major national and regional health plans are collaborating as founding partners of XPRIZE Rapid Covid Testing: Blue Shield of California, Cambia Health Solutions, Inc, Health Care Service Corporation, GuideWell Mutual Holding Corporation, Horizon Healthcare Services, Inc. (NJ), BlueCross BlueShield of South Carolina. The Anthem Foundation and Anthem, Inc., serve as the Founding Anchor Partners. Supporting partners include leading healthcare, laboratory and technology companies: Google, Amazon, Ilumina, Ancestry, Thermo Fisher Scientific, Exact Sciences, Centerview Partners, Twist Bioscience, Opentrons, HudsonAlpha Institute for Biotechnology, and Testing For America.

ABOUT DECISION DIAGNOSTICS CORP
Decision Diagnostics Corp. is the leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters. DECN's products are designed to operate efficiently and less expensively on certain glucose meters already in use by almost 7.5 million diabetics worldwide. With newly inspired technology, and diabetic test strips already in the final stages of development, DECN products compete on a worldwide scale with legacy manufacturers currently selling to 71+ percent of a $15+ billion at-home testing market.

The company's new GenViro!™ products designed to test for Covid-19 are not yet available in the United States and hopefully should soon be available in Puerto Rico, but Emergency (EUA) Waivers are in process with the U.S. FDA with additional submissions to take place in the near future. The company has also signed an agreement with an FDA and CLIA certified US, Pennsylvania-based testing partner to complete testing per current FDA guidelines and continues to look forward to the FDA authorization of its EUAs.

Beyond all of our testing activities, the company has received word from several of its large GenUltimate! blood glucose product distributors who are seeking to have GenViro! added to their Amazon product offerings upon FDA approval. Currently, Amazon only offers special licenses for point of care and professional use medical products, which would preclude the individual use GenViro! Kit from being available on Amazon, even after FDA approval is secured. Two of the company's GenUltimate! product distributors have these "professional use" arrangements with Amazon, with a third distributor application in the works, although the company may determine that it is in its best interest to offer limited exclusivity to one distributor once FDA authorization is achieved.

The company continues to recruit and accept applications from prospective domestic and international distributors. Inquiries can be directed to info@decisiondiagnostics.co.

Forward-Looking Statements:
This release contains the company's forward-looking statements which are based on management's current expectations and assumptions as of November 20, 2020, regarding the company's business and performance, its prospects, current factors, the economy, and other future conditions and forecasts of future events, circumstances, and results.

CONTACT INFORMATION:
Decision Diagnostics Corp.
info@decisiondiagnostics.co
www.genultimate.com
www.genultimatetbg.com
www.pharmatechdirect.com

ADDITIONAL CONTACT INFORMATION:
Decision Diagnostics Corp.
Shep Doniger 561-637-5750
sdoniger@bdcginc.com

XPRIZE
XPRIZE, a 501(c)(3) nonprofit, is the global leader in designing and implementing innovative competition models to solve the world's grandest challenges. Active competitions include the $20 Million NRG COSIA Carbon XPRIZE, the $10 Million Rainforest XPRIZE, the $10 Million ANA Avatar XPRIZE, the $5 Million IBM Watson AI XPRIZE and the $5 Million XPRIZE Rapid Reskilling. For more information, visit xprize.org.

ABOUT THE XPRIZE PANDEMIC ALLIANCE
The XPRIZE Pandemic Alliance is a global coalition that combines the power of collaboration, competition, innovation, and radical thinking to accelerate solutions that can be applied to Covid-19 and future pandemics. For information about the XPRIZE Pandemic Alliance and to join the fight, please visit covid19.xprize.org.

SOURCE: Decision Diagnostics Corp.

ReleaseID: 617804

Brian Hynes isn't your typical entrepreneur. Having practiced law for over twenty-two years, Brian Hynes put it all on the line in 2018 to focus on his finance businesses. Featured in an exclusive interview with IdeaMensch, Brian Hynes reveals some of his top secrets behind his continuous professional success.

CHICAGO, IL / ACCESSWIRE / November 23, 2020 / Brian Hynes was interviewed for IdeaMensch, a digital interview platform for entrepreneurs and industry leaders. With the purpose of helping innovative individuals bring their stories to life, IdeaMensch shared some of Brian Hynes' most valuable pieces of advice.

While Brian was still practicing law, he founded several speciality finance companies including Vendor Assistance Program, LLC (VAP), MuniBuy LLC, Bluestone Capital Markets and Blue Stone Finance. Based in a belief that maintaining good relationships and strong people skills can help you grow your business, Brian Hynes successfully purchased over $6 billion of sovereign and government receivables. As the Founder and Manager of each entity, Brian Hynes credits his success to staying open minded and listening to multiple perspectives.

Another secret to Brian Hynes' success? Waking up early. "My day always starts by 5am. I usually read, workout and prep for the day. Once 9am hits, I'm on the phone all day." When outlining a habit that makes Brian more productive as an entrepreneur, he explained that you shouldn't listen to the critics. Brian Hynes understands that not everyone you meet is going to believe in your idea, but "you have to believe in what you are doing. If you don't really believe in what you're doing, then something new is never going to get done."

Brian Hynes explained that his mistakes are what have made him who he is today: "I tried to launch a hedge fund-of-funds in 2008. It was horrible timing and a venture that effectively bankrupted me. I didn't let this failure define me. Rather I picked myself up and looked into what existing problem I could find a solution for. This is the foundation for every successful entrepreneur."

Lastly, the interview ties up with a particularly relevant piece of advice for anyone struggling during the COVID-19 pandemic: "During moments of crisis, chaos or storm, I always maintain that ‘everything will be fine.'"

Those interested in reading the full interview can do so here.

About Brian Hynes

Brian Hynes earned his undergraduate degree from the University of Illinois and his law degree from Loyola University Chicago. After practicing law for twenty-two years, Brian has now re-directed his focus to finding success in the financial landscape.

While practicing law, Brian founded various specialty finance companies including Vendor Assistance Program, LLC (VAP), MuniBuy, LLC, Bluestone Capital Markets and Blue Stone Finance. Collectively those companies have purchased over $6B of sovereign, government receivables.

Contact

Cody Williams
cwilliams@vendorassistance.com

SOURCE: Brian Hynes

ReleaseID: 617942

TORONTO, ON / ACCESSWIRE / November 23, 2020 / StageZero Life Sciences, Ltd. (TSX:SZLS) ("StageZero" or the "Company") announced today an operational update on its COVID-19 testing and operations.

"We are pleased with the Quarter and the tremendous amount of hard work our team has put into making this the Company's largest quarter ever in revenue." said James Howard-Tripp, Chairman and CEO of StageZero Life Sciences. "We have significantly upgraded our capabilities through increasing the number of laboratory staff, aggressively building up an inventory of supplies, paying down the accounts payable and introducing new tests. We have also greatly increased the number of groups we are now testing for and expect this to contribute to revenue growth as we move forward."

Operational Highlights

Revenue increase of more than four times all of 2019.
$1.5 million cash received significantly exceeds projected operating costs of $900,000 per quarter.
Partnered with more than 50 groups on testing (Q2: 5 groups).
Momentum in testing is continuing into Q4.
Announced preferred lab status for the Government of Barbados for COVID-19 testing to begin to safely allow tourist air travel to commence.
Partnered with Ichor Blood Services to process tests for players in the IIHF World Junior Championships.
Introduced at home collection for PCR testing using saliva and monitored via telehealth.
Introduced a respiratory panel (Cost of $725).
Expanding laboratory footprint and automation in preparation for Aristotle introduction.

Our partner Ichor Blood Services announced today an expansion of COVID-19 testing (https://www.newswire.ca/news-releases/ichor-blood-services-expands-covid-19-travel-testing-program-to-include-travel-to-hawaii-885018751.html) with an agreement with the State of Hawaii as well as initiation of testing for travel to China.

The Company reports its revenue on a cash received basis. This is in accordance with standard accounting practices in the US for laboratories that bill customers and insurance. As a result, some revenue generated in one quarter will be reported in the next or following quarters. The Company's cash balance at the end of September 30, 2020 was US$1.79M.

The Company will schedule an analyst update call following completion of its current prospectus offering.

The Company's financial statements and management discussion and analysis are available on www.sedar.com.

About StageZero Life Sciences, Ltd.

StageZero Life Sciences is dedicated to the early detection of multiple disease states through whole blood. The Company operates a CAP accredited and CLIA certified high complexity reference laboratory based in Richmond, Virginia. A specialist in PCR testing for the early identification of Cancer through blood, the Company is uniquely positioned to provide both COVID PCR testing (swab) and blood test analysis (Antibody testing). Our full service, telehealth platform includes access to physicians and phle1.7botomist who can prescribe and draw samples for individuals and groups. As we provide COVID-19 test during this Pandemic, we continue making progress with our mission to eradicate late stage cancers through early detection. Our next generation test, Aristotle®, is a multi-cancer panel for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer. www.stagezerolifesciences.com

A preliminary prospectus containing important information relating to the securities described in this document has been filed with the securities regulatory authorities in Ontario, British Columbia and Alberta. A copy of the preliminary prospectus, and any amendment, is required to be delivered with this document.

The preliminary prospectus is still subject to completion. There will not be any sale or any acceptance of an offer to buy the securities until a receipt for the final prospectus has been issued.

This document does not provide full disclosure of all material facts relating to the securities offered. Investors should read the preliminary prospectus, the final prospectus and any amendment for disclosure of those facts, especially risk factors relating to the securities offered, before making an investment decision.

Forward-Looking Statements

This press release contains forward-looking statements identified by words such as "expects", "will" and similar expressions, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties that could cause the Company's actual events to differ materially from those projected herein. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements, except as required by law.

Company Contacts:

James R. Howard-Tripp
Chairman & CEO
jht@stagezerols.com
Tel: 1-855-420-7140 Ext. 1

Rebecca Greco
Investor Relations
rgreco@stagezerols.com
Tel: 1-855-420-7140 Ext. 1838

SOURCE: StageZero Life Sciences Ltd.

ReleaseID: 617932

Market players are focusing on making consumers aware of the benefits of their products, as well as bringing accessible and affordable products to explore the market prospects.

DUBAI, UAE / ACCESSWIRE / November 23, 2020 / Future Market Insights: According to Future Marketing Insights (FMI) recent study, the global nutricosmetics market is anticipated to reflect at a CAGR of over 8% during the forecast period, 2020-2030. The growth can be primarily attributed to rising concern for personal care and growing awareness among consumers regarding the side effects of chemical components in their cosmetic products.

"Market players are targeting regions such as South & East Asia wherein the consumers are getting health conscious as well as there is a rise in disposable income. Players are working on launching premium products as accessibility and penetration are higher in contrast to mass products" comments the FMI analyst.

Request a report sample to gain a comprehensive market insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-11627

Nutricosmetics Market – Key Highlights

North America will remain the largest market with one-fifth of the overall market share
Multi-functional segment will record a high growth pace throughout the assessment period.
Supplements will remain the key beneficiary holding around 80% of the market share.
Medium range products are likely to lead by the price range segment over the forecast period.
Growth foreseen in the departmental store's segment will remain high among other categories.

Nutricosmetics Market – Drivers

Nutricosmetics market is foreseeing rising demand as a result of their organic and natural components offering a holistic beauty regimen for hair, nails, and skin along with taking care of the person's health.
Growing consumer's preference for wellness and natural ingredients propelling the market growth.
Introduction of micro-biome skincare products is creating significant opportunities for manufacturers.

Nutricosmetics Market – Restraints

Low awareness and adaptability among consumers regarding the long-term benefits of these products is hindering market growth.
Consumer's unwillingness to shift from topical cosmetic products likely to be a major challenge for the companies.

For any Queries Linked with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-11627

COVID-19 Impact on the Market

The nutricosmetics market has been impacted by the COVID-19 induced lockdown across the globe. Production has been hindered due to disruption in transport ensuing in a lack of raw materials. Furthermore, growing awareness among consumers has led to spending on only essential for survival products. As the markets are gradually regaining their growth pace, the nutricosmetics market is also anticipated to regain normalcy in the short term.

Competitive Landscape

Key players operating in the global nutricosmetics market include Herbalife Nutrition Ltd., Pfizer Inc., Amway Corporation, Viviscal Limited, Phyto Botanical Power, Everest NeoCell LLC, 21st Century HealthCare, Inc., Amazing Nutrition, Nature's Bounty, PureLogical International, Nutrawise health & beauty corporation, Ivy Bears, MartiDerm, Vitabiotics Ltd., Shiseido Co. Ltd., Origo Cosmecuticals Pvt. Ltd. and H&H Group.

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/11627

About the Study

The study offers readers a comprehensive assessment of the nutricosmetics market. Global, regional and national-level analysis of the latest trends influencing the market is covered in this FMI report. The study provides insights on the basis of product type (supplements, and beauty beverages/drinks), primary function (skin care, sun care, anti-aging, radiance & glow, anti-acne/pimple, hair & nail care, weight management, and multi-functional), price range (economy, mid-range, and premium), distribution channel (hypermarkets/supermarkets, convenience stores, specialty stores, direct selling, departmental stores, e-Commerce, and other retail formats) , across key regions (North America, Latin America, Europe, China, Asia Pacific, Middle East & Africa).

Explore FMI's Coverage of the Consumer Product Industry

Waterless Cosmetic Market: Get insights on the Waterless Cosmetic market through FMI's report covering detailed quantitative and qualitative analysis for projection period 2020 – 2030.

Gemstone Cosmetics Powder Market: FMI's exhaustive study on the global gemstone cosmetics market covers the latest trends, innovations, key players, and popular strategies for the period 2018 – 2028.

Vegan Cosmetics Market: Obtain detailed analysis on the vegan cosmetics market through FMI's report covering competitive analysis, key regions, and segmental analysis for 2020 – 2030.

About Future Market Insights

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact

Mr. Abhishek Budholiya

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

MARKET ACCESS DMCC Initiative

For Sales Enquiries: sales@futuremarketinsights.com

For Media Enquiries: press@futuremarketinsights.com

Report: https://www.futuremarketinsights.com/reports/nutricosmetics-market

Press Release Source: https://www.futuremarketinsights.com/press-release/nutricosmetics-market

SOURCE: Future Market Insights

ReleaseID: 617919

Market players are focusing their resources on strategic acquisitions and collaborations to strengthen the scope of product development, thus consolidating their market position.

ROCKVILLE, MD / ACCESSWIRE / November 23, 2020 / The water electrolysis machine market will reflect an impressive CAGR of 7% throughout the projected period, 2020-2030. The growth can be primarily attributed to extensive use in the downstream procedure of DNA and protein separation. The market will be majorly employed in the chemical sector, such as the manufacturing of ammonium and methanol fertilizers, along with extensive applications of hydrogen formation in the petroleum sector for treating crude oil. These devices are further likely to discover major roles in hydrogen generation for electronics, steel, and pharmaceutical applications.

" Increasing global demand for carbon-free, sustainable sources of energy, extending applications scope in several end-use sectors, and enhancements in the incorporation of renewables for power to gas facilities are prominent aspects that will propel the market growth over the assessment period." says the Fact.MR report.

Request a report sample to gain comprehensive market insights at

https://www.factmr.com/connectus/sample?flag=S&rep_id=5248

Key Takeaways

Asia Pacific is anticipated to remain the biggest market, however, North America will witness rapid growth throughout the forecast period.
Proton exchange membranes will be accounting for a larger market share over the forecast period.
The chemicals industry will remain dominant in the dominant application category by 2030 end.
The global water electrolysis machine market is expected to reach a market valuation of US$ 12 Bn towards 2030 end.

Driving Factors

Government policies for eco-friendly technologies and fuel cell r&d will offer critical expansion prospects for market players.
Advances in proton exchange membrane technology, along with ideal applications in variable temperature and high-pressure settings, are propelling the market growth.

Constraints

Low-cost delivery of hydrogen is a prominent challenge in the market when it is created from renewable sources.
An alternative for water electrolysis and the high cost associated with water electrolyzer is projected to decelerate the market growth.

Anticipated Market Impact by COVID-19 Outbreak

Several end-user sectors that are active in the water electrolysis machines market have been impacted by the COVID-19 outbreak, impacting the short-term demand. On the other hand, the market is anticipated to foresee stable recovery by 2021, as private and public investments towards hydrogen generation and renewables are likely to regain impulse in the near future.

Explore the global Water Electrolysis Machine market with 90 figures, 60 data tables, along with the table of contents of the report. You can also find detailed segmentation on https://www.factmr.com/report/5248/water-electrolysis-machine-market

Competition Landscape

Key players identified in the global market are Kobel Co Eco-Solutions, Air Products and Chemicals Inc., AREVA H2Gen, C&E Environmental Technology Co. Ltd., Asahi Kasei Corporation, Toshiba Lifestyle Products & Services Corporation, ThyssenKrupp AG, Teledyne Technologies Inc., and Enagic.

More on the Report

The Fact.MR's market research report provides in-depth insights into the water electrolysis machine market. The market is scrutinized based on type (proton exchange membrane, alkaline water electrolysis, and others), input power (below kW, 2 kW – 5 kW, and above 5 kW), hydrogen production (below 500, 500 -2000, and above 2000), and application (chemicals, petroleum, steel plants, pharmaceuticals, electronics & semiconductors, power plants, and others), across five major regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa (MEA)).

Explore Wide-ranging Coverage of Fact.MR's Industrial Goods Landscape

Water Service Module for Steam Boilers Market: Find insights on the water service module for steam boilers market with analysis of segments, statistics, influencers, market players, and business strategies adopted over the forecast period 2018-2027.

Mobile Water Treatment Systems Market: Fact.MR's report on the mobile water treatment systems market offers insights on the market during 2020-2030, including restraints, revenue sources, market leaders, and market strategies.

Underwater Signaling Devices Market: Read an analysis of the underwater signaling devices market with insights on growth factors, opportunities, restraints, regional market forecast, regulatory policies, and strengths of market leaders.

About Fact.MR

Fact.MR is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. Fact.MR is headquartered in Dublin, and has offices in Dubai. Fact.MR's latest market research reports industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition.

Contact:

Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
PR- https://www.factmr.com/media-release/1711/global-water-electrolysis-machine-market

SOURCE: FactMR

ReleaseID: 617933

TORONTO, ON / ACCESSWIRE / November 23, 2020 / The global COVID-19 pandemic has created a worldwide demand for PPE (Personal Protective Equipment).

This pandemic's sudden spread has left many countries in Europe scrambling to procure PPE for their medical personnel. As a consequence of the high demand, the market for PPE has become littered with scammers and fake products.

Enter Oliver Knox, a Canadian based entrepreneur, and his childhood friend and business associate, Martin Macek. The two entrepreneurs hailing from the Czech Republic noticed a dangerous mass shortage of PPE in their home country, and immediately began sourcing certified PPE earlier this May.

Since then, their business has grown to become ELIT PPE Supplies.

ELIT PPE Supplies began when Oliver himself, along with fellow business investor Alexander Sasha Reljanovic, invested a large amount of personal capital to purchase stocks of PPE upfront. This eliminated the deposits, holds and other escrow solutions many other competitors used that often resulted in delays, payment errors and scams.

The aim of Oliver and his associates was to connect PPE sellers with buyers, in light of the lack of credible, reliable and affordable products on the current market. This helped establish ELIT as the reliable PPE source it is today.

ELIT PPE now supplies the majority of hospitals in the Czech and Slovak region, in addition to many hospitals and clinics in Austria, Poland, Hungary. Their next move is to enter the German market.

All the inventory and stock of ELIT PPE is currently kept on sight at a warehouse facility located in the Czech region managed by Vito Caraffa. Caraffa directs over 25 employees that manage the quality and integrity of the products going out for client delivery.

ELIT PPE is steadily cementing itself as the premier supplier of vetted and certified PPE. They are the first in the market to offer their clients shipments as fast as 48 hours, and flexibility in payment for up to 7 business days.

The company also boasts a specialization in client relations under client director Martin Macek, who ensures that all problems and concerns aren't swept under the rug, and are given the proper attention to ensure complete client satisfaction.

With all that's going on in the world right now, it seems that in this case, the EU medical community can certainly count on Oliver and his ELIT team.

CONTACT:
Oliver Knox
647-574-0766
Toronto, ON

SOURCE: Variance Marketing

ReleaseID: 617691

LOS ANGELES, CA / ACCESSWIRE / November 23, 2020 / Compare-autoinsurance.org (https://compare-autoinsurance.org) is a top auto insurance brokerage website, providing car insurance quotes online from trustworthy agencies all over the United States. This website has recently launched a guide that explains how shopping online will help drivers find affordable car insurance.

Getting online car insurance provides multiple benefits to prospective drivers. The internet is the biggest repository of knowledge worldwide and used properly, it can save drivers a lot of money.

Getting car insurance online is very easy and fast. It is difficult to reach many places in a short time, especially when living in areas with intense traffic. A driver can waste several hours on the roads, just to go to a company, ask for prices, analyze offers and return home. Shopping online removes all these unpleasant details. Drivers can get quotes whenever they want, wherever they want. The purchase can be completed with just a few clicks, from the comfort of a bedroom.
Create a list of reputable insurance companies. It is important to work only with companies known to be trustworthy. When evaluating a potential insurer, look for customer satisfaction indexes, like J.D. Powell's customer satisfaction rating and the insurer's financial solvency. Again, drivers can check more info online. Also, look for companies with low complaint ratios.
Get online quotes from those companies. After selecting 4-5 insurance companies, make sure to obtain quotes. Provide accurate and honest data about the car, driving history and recent traffic violations.
Discounts for buying online. To encourage people to purchase car insurance policies online, insurers, in collaboration with partners, offer lucrative discounts.
Get coverage instantly. After the purchase is finished, the client is automatically insured. Furthermore, the company will send a digital copy of proof of insurance. The client can save this copy to any of his mobile devices and show it whenever is asked for.
Customize coverage limits. Online questionnaires are highly customizable, allowing the driver to create coverage suitable for his budget. The user can select liability coverage limits, full coverage deductibles, payment options, and extra riders. The price will fluctuate by tens-hundreds of dollars, depending on the user's selections.

For additional info, money-saving tips, and free car insurance quotes, visit https://compare-autoinsurance.org.

Compare-autoinsurance.org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc.

"Getting car insurance online is extremely fast, efficient and comfortable. You do not have to wait in queues, deal with impolite agents or participate in a nerve-wracking negotiation", said Russell Rabichev, Marketing Director of Internet Marketing Company.

CONTACT:

Company Name: Internet Marketing Company
Person for contact: Daniel C
Phone Number: (818) 359-3898
Email: cgurgu@internetmarketingcompany.biz
Website: https://compare-autoinsurance.org

SOURCE: Internet Marketing Company

ReleaseID: 617904

ATLANTA, GA / ACCESSWIRE / November 23, 2020 / Managing a team requires making complex decisions that are not just imperative to the success of your business goals, but also maximize the potential growth of your employees. While some are born with the natural instincts to lead, others require time and training to develop the skills and critical thinking necessary to lead effectively.

Recalling his years of leadership in business, Deepak Agarwal, c-suite executive and long-time entrepreneur in various industries, recommends that leaders embrace a strong set of values that help pave the way for success. For Deepak Agarwal, these guiding principles are the basis of almost every decision made throughout one's leadership journey and can help ensure that actions guide, inspire and motivate others.

The following lists Deepak Agarwal's fundamentals to develop and enhance leadership skills.

1. Lead by Example

There are many different leadership styles, and what works for one leader may not work for another. However, Deepak Agarwal recognizes that there are certain philosophies that are found in all styles of leadership – for example, showing people how to do a good job rather than simply telling them what to do.

2. Recognize Uncertainty and Adapt

We live in an ever-changing world where anything can happen; Therefore, to lead effectively, leaders must prepare themselves for uncertainty by taking a fresh look at their business and team, anticipating and mitigating risk, and creating contingency plans for overcoming obstacles. While leaders cannot predict the future, it is important that they keep a pulse on dynamic shifts within their industry, forecast how it could impact business, and prepare accordingly.

3. Promote Diversity and Inclusion

Welcoming diversity is one of the most important values leaders can instill in their company culture. A diverse and inclusive workforce establishes value in a variety of perspectives and encourages innovation, ultimately increasing the likelihood of success. Diverse organizations also often benefit from more impactful collaboration amongst employees. "Strong leaders embrace the benefits of working with others who challenge their perspective and help them see the world, and their business, more holistically," notes Dee Agarwal.

4. Nurture Future Leaders

As a leader, you should take time to ensure everyone in the organization has the opportunity to develop their skills and define a career path that suits their abilities and ambitions. Each employee should make improvements over time that deepens their value to the organization. This requires time and investment in developing talent and training programs. Ultimately, when employees are educated as leaders, they will be motivated to take more ownership in the work they do.

Aligning leadership principles with expectations and goals can elevate your organization to new heights. While there are many different formulas to become a successful leader, the above principles show that, with an open mindset and ongoing flow of ideas, a strong foundation can be built to fuel your leadership journey.

Contact:

Andrew Mitchell
Email: media@cambridgeglobalmedia.com
Phone: 404-955-7133

SOURCE: Deepak Agarwal

ReleaseID: 617927

MIDLAND, VA / ACCESSWIRE / November 23, 2020 / Smith-Midland Corporation (NASDAQ:SMID).

Easi-Set Worldwide, precast concrete product licensor and subsidiary of Smith-Midland Corporation, licensed producer announcement.

Easi-Set announced the expansion of one of its current J-J Hooks licensed producers into an established market area. After the successful launch of Mack Industries J-J Hooks highway safety barrier production in their Michigan based precast concrete plants last year, they have added an additional license for their facility in Florida.

"Mack is doing everything right in their roll out of this product. Their level of commitment to this opportunity has been impressive," said Art Miles, president of Easi-Set. "This move will add needed capacity to our expanding Florida market."

As one of the country's most experienced precasters Mack offers both ready-mix concrete and a broad range of precast concrete products from utility to road construction and building products from nine locations covering the Eastern U.S. from Michigan to Florida. Their 87 years of experience along with both PCI and NPCA plant certifications provide customers a reliable purchasing source.

J-J Hooks is proving itself to be a natural extension of Mack Industries product line for their road contracting clientele. Their Astatula, Florida plant is centrally located, easily serving the entire state.

About J-J Hooks Precast Concrete Highway Safety Barrier

J-J Hooks is the industry's most successful connection design with well over 15 million linear feet provided to highway construction projects in North America and abroad. J-J Hooks freestanding, pin-down and bolt-down designs have been MASH TL3 tested and are available from over 40 producers.

Discover more about J-J Hooks and its network of precast concrete licensed producers by calling 800-547-4045 or visiting www.JJHooks.com.

About Easi-Set Worldwide

Easi-Set Worldwide, a wholly owned subsidiary of Smith Midland Corporation, a public company, licenses the production and sale of Easi-Set products and provides diversification opportunities to the precast industry worldwide. For more information about precast product licensing opportunities, contact Easi-Set by calling 800-547-4045 or visiting www.EasiSet.com.

Contact: info@easiset.com

SOURCE: Smith-Midland Corporation

ReleaseID: 617755

LAS VEGAS, NV / ACCESSWIRE / November 23, 2020 / Golden Triangle Ventures, Inc. (OTC PINK:GTVH), a strategic consulting company doing business in the Health, Entertainment, and Technology sectors, is pleased to announce that the Board of Directors has elected to explore the opportunity to spin off Global Health Services and dividend all of its shareholders.

Global Health Services is a wholly owned subsidiary of Golden Triangle Ventures under its Health Division. The Board of Directors have elected to explore the opportunity to Spin off its Health division through a Form 10 Filing which is anticipated to be filed in February. The company currently does business in the Medical PPE space and the CBD space, and management is in the process of building an extensive online portal which will support all of the multiple verticals under the company and provide a one stop shop for all of the company products and services. In addition, management is working on acquiring an array of profitable assets and projects with many impressive additions to its senior team involved.

More information on Global Health Services can be found on the company corporate website here: www.GTVhealth.com.

The company election to explore this spin off of Global Health Services into its own trading entity supports Golden Triangle Ventures core business model to help its business achieve their overall goals. Golden Triangle Ventures believes that the company deserves to be trading under its own entity as expectations of this division transpire in the months ahead. All shareholders in Golden Triangle Ventures will get a 1:1 share dividend in Global Health Services once the company Form 10 Filing becomes effective. Once Global Health Services officially spins off Golden Triangle Ventures, management intends to make another exciting acquisition to fill the third corner of its triangular business model. The company management team has been working towards this goal for several months and everything is being prepared to accomplish all the above goals.

Steffan Dalsgaard, CEO of Golden Triangle Ventures, states, "Our vision from day one has been to acquire companies that we truly believe in, give them all the resources necessary to become the companies we envision them becoming, then spin them off into their own entities once they are ready to get to the next level on their own. We strongly believe that Global Health Services is ready to get to the next level and become an amazing, multi-functioning, global health business. The team we intend to put in place and the products and services we will be offering are truly groundbreaking. We believe that our shareholders will be greatly rewarded upon our success, and the new company Golden Triangle Ventures intends to acquire will be another unique business that we believe to have an exceptionally bright future."

About Golden Triangle Venture

Golden Triangle Ventures, Inc. or "GTV" is a multifaceted consulting company pursuing ventures in the Health, Entertainment and Technology sectors. The company aims to purchase, acquire and/or joint venture with established entities within these areas of business. In addition, GTV provides a professional corporate representation service to different companies in these sectors while consulting on a variety of different business development objectives. The goods and services represented are driven by innovators who have passion and commitment in these marketplaces. The company plans to utilize relationships and create a platform for new and existing businesses to strengthen their products and/or services. The three points of the Golden Triangle exclusively represent the three sectors this company aims to do business in.

Golden Triangle Ventures Website: http://www.GoldenTriangleInc.com.

Forward-Looking Information

This news release may include "forward-looking statements" including forecasts, estimates, expectations, and objectives for future operations including but not limited to its ability to conclude a business combination with a third party, sale of assets, return of capital or initial public offering and a secondary listing on the OTC as a result of aforementioned and its ability to fund the exploration of its assets through the raising of equity or debt capital or through funding by a joint venture partner that are subject to a number of assumptions, risks, and uncertainties, many of which are beyond the control of Texas Oil & Minerals, Inc. including but not limited to capital markets and securities risks and continued development success on technology. There can be and are no actual or implied guarantees that any of the above activities will be completed or completed on terms acceptable to the Company and its shareholders or approved by any regulatory authority having jurisdiction. Such forward-looking information represents management's best judgment based on information currently available. No forward-looking statement can be guaranteed, and actual future results may vary materially. Texas Oil & Minerals, Inc. does not assume the obligation to update any forward-looking statement, except as required by applicable law. For short updates on the company, please visit the corporate Twitter page @GTV_Inc.

CONTACT INFORMATION

Golden Triangle Ventures, Inc.
3430 East Russell Road
Suite 301-18
Las Vegas, NV 89120
1-800-469-2614

SOURCE: Golden Triangle Ventures, Inc.

ReleaseID: 617896